Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 12 | 2023 | 38 | 5.790 |
Why?
|
| Ventral Tegmental Area | 13 | 2023 | 26 | 4.950 |
Why?
|
| Dopaminergic Neurons | 10 | 2023 | 22 | 4.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2023 | 22 | 3.150 |
Why?
|
| Nicotinic Agonists | 4 | 2020 | 14 | 1.740 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 25 | 1.680 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2023 | 125 | 1.330 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 39 | 1.300 |
Why?
|
| Ethanol | 2 | 2021 | 45 | 1.270 |
Why?
|
| Glioblastoma | 2 | 2020 | 6 | 1.230 |
Why?
|
| Spheroids, Cellular | 3 | 2020 | 11 | 1.220 |
Why?
|
| Animals | 18 | 2024 | 1711 | 1.210 |
Why?
|
| Pregnancy | 8 | 2023 | 89 | 1.180 |
Why?
|
| RNA, Messenger | 5 | 2021 | 68 | 1.140 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2018 | 10 | 1.070 |
Why?
|
| Dopamine | 6 | 2023 | 26 | 1.010 |
Why?
|
| MicroRNAs | 4 | 2021 | 53 | 1.010 |
Why?
|
| Neurons | 4 | 2023 | 109 | 1.000 |
Why?
|
| Rats | 9 | 2023 | 241 | 1.000 |
Why?
|
| Prefrontal Cortex | 3 | 2011 | 34 | 1.000 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 69 | 0.970 |
Why?
|
| Signal Transduction | 3 | 2020 | 216 | 0.840 |
Why?
|
| Maternal Exposure | 2 | 2021 | 5 | 0.830 |
Why?
|
| Nitriles | 2 | 2020 | 11 | 0.820 |
Why?
|
| Sulfones | 2 | 2020 | 10 | 0.820 |
Why?
|
| Gene Expression Profiling | 3 | 2019 | 48 | 0.770 |
Why?
|
| Cell Survival | 2 | 2020 | 54 | 0.730 |
Why?
|
| Female | 8 | 2023 | 2523 | 0.670 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 2 | 0.670 |
Why?
|
| Neuroglia | 1 | 2020 | 8 | 0.660 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 3 | 0.660 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 22 | 0.660 |
Why?
|
| NF-kappa B | 1 | 2020 | 9 | 0.650 |
Why?
|
| Actin Cytoskeleton | 1 | 2020 | 11 | 0.650 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 35 | 0.650 |
Why?
|
| Apoptosis | 1 | 2020 | 46 | 0.640 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 55 | 0.640 |
Why?
|
| Gene Expression | 1 | 2020 | 49 | 0.610 |
Why?
|
| Hippocampus | 2 | 2010 | 59 | 0.610 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2018 | 8 | 0.580 |
Why?
|
| Male | 8 | 2022 | 2491 | 0.540 |
Why?
|
| Mesencephalon | 1 | 2016 | 9 | 0.490 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 12 | 0.490 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 24 | 0.480 |
Why?
|
| Action Potentials | 2 | 2016 | 18 | 0.450 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 160 | 0.430 |
Why?
|
| Carbachol | 2 | 2010 | 8 | 0.410 |
Why?
|
| Markov Chains | 2 | 2010 | 19 | 0.410 |
Why?
|
| Receptors, AMPA | 1 | 2011 | 3 | 0.360 |
Why?
|
| Humans | 6 | 2024 | 4936 | 0.360 |
Why?
|
| Transcriptome | 2 | 2023 | 43 | 0.350 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 10 | 0.350 |
Why?
|
| Oscillometry | 1 | 2010 | 6 | 0.320 |
Why?
|
| Mice | 6 | 2024 | 685 | 0.290 |
Why?
|
| Ganglionic Stimulants | 2 | 2019 | 5 | 0.230 |
Why?
|
| Optogenetics | 2 | 2023 | 5 | 0.230 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 318 | 0.220 |
Why?
|
| Acute Pain | 1 | 2024 | 4 | 0.210 |
Why?
|
| Cocaine | 1 | 2023 | 5 | 0.210 |
Why?
|
| Nociceptive Pain | 1 | 2023 | 2 | 0.200 |
Why?
|
| Serotonin | 1 | 2023 | 4 | 0.200 |
Why?
|
| Electrophysiology | 2 | 2014 | 24 | 0.190 |
Why?
|
| Tobacco Use Disorder | 1 | 2023 | 49 | 0.180 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2022 | 2 | 0.180 |
Why?
|
| GABAergic Neurons | 1 | 2022 | 2 | 0.180 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 7 | 0.170 |
Why?
|
| Vimentin | 1 | 2020 | 5 | 0.170 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 10 | 0.170 |
Why?
|
| Coculture Techniques | 1 | 2020 | 9 | 0.170 |
Why?
|
| Receptor, Notch1 | 1 | 2020 | 7 | 0.170 |
Why?
|
| Astrocytes | 1 | 2020 | 16 | 0.170 |
Why?
|
| Immunoblotting | 1 | 2020 | 8 | 0.160 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 27 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 21 | 0.160 |
Why?
|
| Models, Biological | 1 | 2020 | 124 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 8 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 14 | 0.150 |
Why?
|
| Nucleus Accumbens | 3 | 2023 | 7 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 9 | 0.150 |
Why?
|
| Smoking | 1 | 2018 | 89 | 0.140 |
Why?
|
| Gene Ontology | 1 | 2016 | 4 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2016 | 16 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 12 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2016 | 22 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 19 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 18 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2016 | 28 | 0.120 |
Why?
|
| Software | 1 | 2016 | 57 | 0.120 |
Why?
|
| Entropy | 1 | 2014 | 11 | 0.110 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 8 | 0.090 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2011 | 6 | 0.090 |
Why?
|
| Axotomy | 1 | 2011 | 2 | 0.090 |
Why?
|
| Neural Pathways | 1 | 2011 | 31 | 0.080 |
Why?
|
| Electroencephalography | 1 | 2011 | 73 | 0.080 |
Why?
|
| Nerve Net | 1 | 2010 | 25 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 47 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 28 | 0.080 |
Why?
|
| Algorithms | 1 | 2011 | 241 | 0.080 |
Why?
|
| Time Factors | 1 | 2010 | 163 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 62 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 225 | 0.070 |
Why?
|
| Gyrus Cinguli | 1 | 2024 | 3 | 0.050 |
Why?
|
| Somatosensory Cortex | 1 | 2024 | 10 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2024 | 19 | 0.050 |
Why?
|
| Morphine | 1 | 2023 | 2 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 42 | 0.050 |
Why?
|
| Dorsal Raphe Nucleus | 1 | 2023 | 2 | 0.050 |
Why?
|
| Microdialysis | 1 | 2023 | 4 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2023 | 4 | 0.050 |
Why?
|
| Calcium | 1 | 2023 | 31 | 0.050 |
Why?
|
| Channelrhodopsins | 1 | 2022 | 2 | 0.050 |
Why?
|
| Bicuculline | 1 | 2022 | 3 | 0.050 |
Why?
|
| Optical Imaging | 1 | 2022 | 17 | 0.050 |
Why?
|